Public Profile

RenBio, Inc.

RenBio, Inc., a leading biotechnology firm headquartered in the United States, has been at the forefront of innovative solutions since its inception in 2015. With a strong focus on developing advanced therapeutics and diagnostics, RenBio operates primarily in the biopharmaceutical sector, catering to a diverse range of medical needs. The company is renowned for its proprietary platform that harnesses the power of biologics to create unique treatments for various diseases. RenBio's commitment to research and development has positioned it as a key player in the industry, achieving significant milestones in clinical trials and product launches. With a growing portfolio of core products, RenBio continues to make strides in enhancing patient outcomes and advancing healthcare solutions globally.

DitchCarbon Score

How does RenBio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

RenBio, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

RenBio, Inc.'s reported carbon emissions

RenBio, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor RenBio's future disclosures regarding their climate commitments and any potential strategies they may adopt to mitigate their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. RenBio, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. RenBio, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

RenBio, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Kymab Limited

GB
Research and development services (73)
Updated 7 days ago

AbCellera

CA
Education services (80)
Updated 7 days ago

Leveragen, Inc.

US
Health and social work services (85)
Updated 7 days ago

Alloy Therapeutics, Inc.

US
Health and social work services (85)
Updated 7 days ago

Regeneron

US
Research and development services (73)
Updated 1 day ago

Crescendo Biologics Limited

GB
Research and development services (73)
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers